Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis [Phase 3]

View source ↗

Summary

A Phase III randomized, double-blind, placebo-controlled trial evaluating CM326 for chronic rhinosinusitis with nasal polyps; the study is currently not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• CM326

Snippet

Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | Status: NOT_YET_RECRUITING